Andy Arnold

Andy Arnold is a Senior Director of GMP Audit at GlaxoSmithKline with 40 years of experience in the pharmaceutical industry, encompassing development, new product introduction, technology transfer, and manufacturing across biopharmaceutical and cell and gene therapy sectors. For the past 15 years, Andy has held global audit roles, managing teams across the Americas and EMEA regions. Previously, Andy served as New Product Introduction Manager at SmithKlineBeecham and has held multiple leadership positions at GSK, including GMP Audit Director for both EMEA and the Americas. Currently, Andy is pursuing education at the University of Brighton.